Open Access497 MD-7246, a Delayed-Release Formulation of Linaclotide Targeting Visceral Pain Associated With IBS-D, Does Not Impact Bowel Frequency or Stool Consistency in Healthy Volunteers: Results From Phase I Trial
Author(s) -
Braden Kuo,
Wilmin Bartolini,
Kenneth Tripp,
Ramesh Boinpally,
Niels Borgstein
Publication year - 2019
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000591520.21724.1e
Subject(s) - medicine , tolerability , placebo , irritable bowel syndrome , gastroenterology , interquartile range , constipation , adverse effect , pharmacodynamics , pharmacokinetics , bloating , abdominal pain , pathology , alternative medicine